Notably, in colorectal, breast, and prostate cancers, KLF4 exhibits remarkable context‐dependent and dual roles, acting as either a tumor promoter or suppressor depending on the intricate network of signaling pathways [7, 8, 14, 18, 51, 57]. This evidence concerns the gene KLF4 and prostate carcinoma.